Valion Bio, Inc. (VBIO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-52.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | — | $780.0K | $1.18M | $1.84M | $1.26M | — |
| Cost of Revenue | — | $778.0K | $889.0K | $1.54M | $1.29M | — |
| Gross Profit | — | $2.0K | $287.0K | $299.0K | -$38.0K | — |
| Operating Income | -$7.90M | -$4.48M | -$8.24M | -$10.10M | -$5.63M | — |
| Net Income | -$8.88M | -$5.66M | -$8.24M | -$10.10M | -$8.49M | — |
| EPS (Diluted) | $-7.84 | $-19.68 | $-176.80 | $-104.32 | $-2.43 | — |
| Total Assets | $31.61M | $2.81M | $5.16M | $5.88M | $15.04M | — |
| Total Liabilities | $7.44M | $272.0K | $1.58M | $2.25M | $1.76M | — |
| Shareholders' Equity | $16.80M | $2.54M | $3.58M | $3.63M | $13.27M | -$1.18M |
| Cash & Equivalents | $12.64M | $2.00M | $3.40M | $3.52M | $12.97M | — |
| Operating Cash Flow | -$7.00M | -$5.72M | -$8.51M | -$8.92M | -$5.61M | — |
| Capital Expenditures | $38.0K | $0 | $118.0K | $11.0K | — | — |
| Shares Outstanding | 2.53M | 556.9K | 86.2K | 96.8K | 9.72M | — |